Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1038 | 974 | 1201 | 950 | 1278 | 1432 |
Fund Return | 3.79% | -2.6% | 20.14% | -1.71% | 5.03% | 3.66% |
Place in category | 1482 | 1465 | 1383 | 1515 | 1024 | 639 |
% in Category | 68 | 68 | 64 | 81 | 66 | 68 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Manulife Global Asia REIT AA G | 307.54M | -4.79 | -8.47 | - | ||
Manulife Global Fund Global Equity | 256.03M | 10.92 | 4.87 | 6.85 | ||
Manulife Glbl Fund Asian Eq I3 USD | 109.31M | -17.66 | 4.06 | - | ||
Manulife Glbl Fund Asian Eq Fund I | 109.31M | 15.30 | -1.14 | 4.16 | ||
Manulife Glbl Fund Asian Eq Fund AA | 109.31M | 14.53 | -1.92 | 3.41 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
MFSM European Value Fund A1 USD | 2.34B | 2.78 | -2.06 | 5.87 | ||
MFSM European Value Fund I1 USD | 2.34B | 3.41 | -1.15 | 6.90 | ||
MFSM European Value Fund N1 USD | 2.34B | 2.34 | -2.56 | 5.34 | ||
MFSM European Value Fund W1 USD | 2.34B | 3.41 | -1.33 | 6.66 | ||
JPEurope Equity Plus Fund C perf ac | 2.1B | 17.77 | 10.01 | 6.77 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Novo Nordisk B | DK0062498333 | 5.73 | 748.5 | -0.32% | |
ASML Holding | NL0010273215 | 4.99 | 648.80 | +1.04% | |
AstraZeneca | GB0009895292 | 3.80 | 10,427.6 | -0.44% | |
SAP | DE0007164600 | 3.66 | 225.375 | -0.23% | |
Unilever | GB00B10RZP78 | 2.86 | 56.06 | -0.67% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Sell | Sell | Neutral |
Technical Indicators | Strong Sell | Strong Sell | BUY |
Summary | Strong Sell | Strong Sell | Neutral |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review